TABLE 3.
Substrate | PenA | Vmax | Km | kcat | kcat/Km |
---|---|---|---|---|---|
Nitrocefin | 316a | 159 ± 7.4 | 10.9 ± 2.1 | 4.91 | 446 |
316c | 67.6 ± 4.2 | 3.34 ± 0.7 | 1.01 | 303 | |
392f | 351 ± 7.2 | 38 ± 2.1 | 46.2 | 1,214 | |
AMP | 316a | 1,316 ± 114 | 126 ± 29.5 | 0.18 | 1.45 |
316c | NM | 13.8 | 0.04 | 2.74* | |
392f | 4,087 ± 601 | 1,051 ± 237 | 37.2 | 35.4 | |
AMX | 316a | NM | 2.22* | NM | NM |
316c | NM | 0.88* | 0.09 | 96.9* | |
392f | NM | 74.6* | NM | NM | |
CFZ | 316a | 1,024 ± 106 | 59.5 ± 17.8 | 21.35 | 359 |
316c | 168 ± 5.9 | 12.6 ± 1.8 | 0.63 | 50 | |
392f | 2,390 ± 383 | 255 ± 52.8 | 78.6 | 307 | |
FOX | 316a | NH | NR | NH | NH |
316c | NM | 15.4* | 0.02 | 1.02* | |
392f | NH | NR | NH | NH | |
CRO | 316a | 1,514 ± 389 | 287 ± 117 | 63.1 | 219 |
316c | 253 ± 29.4 | 29.4 ± 8.5 | 0.95 | 32.4 | |
392f | 802 ± 128 | 138 ± 34.4 | 26.3 | 191 | |
CAZ | 316a | NM | NR | NM | NM |
316c | NM | 10.3* | 0.02* | 2.33* | |
392f | NM | NR | NM | NM | |
ATM | 316a | 1,645 ± 211 | 179 ± 61.4 | 3.2 | 17.9 |
316c | NM | 48.1* | 0.15* | 3.2* | |
392f | 1,939 ± 144 | 336 ± 51.9 | 17.6 | 52.5 | |
IPM | 316a | NH | NR | NH | NH |
316c | NH | NM** | NH | NM** | |
392f | NH | NR | NH | NH | |
CLA | 316a | ND | 0.61* | ND | ND |
316c | ND | 17.7* | ND | ND | |
392f | ND | 3.18* | ND | ND |
Units are μMs−1 for Vmax, μM for Km, s−1 for kcat, and mM−1s−1 for kcat/Km. CLA; clavulanic acid. Other antibiotic abbreviations are as listed in Table 1. NR, antibiotic was not recognized by that particular enzyme; NM, the rate of hydrolysis is too slow to be measured accurately; ND, not determined; NH, hydrolysis was not detected after 30 minutes. ∗, Ki was used as Km ; ∗∗, the enzyme was completely inactivated by imipenem and no nitrocefin hydrolysis was detected.